New nanotechnology research study turns brain tumors blue
(Medical Xpress)—In an article published this week in the journal Drug Delivery and Translational Research, researchers from Children's Healthcare of Atlanta and the Georgia Institute of Technology have reported the development of a technique that assists in identifying tumors from normal brain tissue during surgery by staining tumor cells blue. This key finding, developed by a team led by Dr. Barun Brahma, M.D., Children's neurosurgeon and biomedical engineer, and Prof. Ravi Bellamkonda, the Carol Ann and David D. Flanagan Chair in Biomedical Engineering at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, could be a critical technique used in hospitals lacking sophisticated equipment like an MRI, which guides in tumor removal, in preserving the maximum amount of normal tissue and brain function during surgery.
The project began when Children's Dr. Brahma approached the Georgia Tech-based laboratory of Prof. Bellamkonda and wondered if there was a way to manually distinguish a tumor from normal tissue during surgery without using complex equipment that might be unavailable to some health facilities. Prof. Bellamkonda's lab developed a nanocarrier made out of fat that carried a clinically approved dye called Evans Blue. The team demonstrated that these nanocarriers leak out of blood vessels in the tumor margin and stain brain tumors blue. Using tumor cells injected into a rat brain, the team proved that injecting the blue-stained nanocarrers into the blood stream caused the nanocarriers to find their way to the brain tumor and selectively dye it blue while excluding normal brain tissue.
The finding is significant for hospitals worldwide that lack machines to help guide tumor removal, such as an intraoperative MRI machine. This new technique has the potential to help neurosurgeons remove brain tumors in children more accurately all over the world.
Dr. Brahma, Prof. Bellamkonda and other collaborators are developing a range of nanotechnologies designed to treat brain tumors and traumatic brain and spinal cord injuries. Other authors on the report include researchers from the Bellamkonda lab and Biomedical Engineering Assistant Professor Phil Santangelo, an optical imaging expert at Georgia Tech. This collaboration embodies the power and potential of the rapidly growing partnership between Children's and Georgia Tech.
This research effort is in collaboration with the Children's Neurosciences Center. This effort is part of the Emory+Children's Pediatric Research Center led by Children's Healthcare of Atlanta and Emory University, including partnerships with the Georgia Institute of Technology and Morehouse School of Medicine.
This research was funded by Ian's Friends Foundation in Atlanta and the Georgia Cancer Coalition.
More information: link.springer.com/… 6-013-0139-x
Journal reference:
Drug Delivery and Translational Research
Provided by Children's Healthcare of Atlanta
-
Imipramine blue: Novel compound halts tumor spread, improves brain cancer treatment in animal studies
Mar 28, 2012 |
not rated yet |
0
-
New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome
Feb 02, 2009 |
not rated yet |
0
-
University Hospitals Seidman Cancer Center tests novel drug that makes brain tumors glow hot pink
Dec 01, 2011 |
not rated yet |
0
-
New probe provides vital assist in brain cancer surgery
Jul 24, 2012 |
not rated yet |
0
-
'SpectroPen' could aid surgeons in detecting edges of tumors
Oct 11, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Team finds mechanism linking key inflammatory marker to cancer
In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.
Cancer
25 minutes ago |
not rated yet |
0
|
Study of young Israelis emphasizes need for avoidance of sun exposure for the very young
A new study conducted using extensive medical records of over one million Israeli adolescents before military service shows clearly how exposure to the Israeli sun of young, light-skinned children increases substantially ...
Cancer
2 hours ago |
not rated yet |
0
Genetic diversity within tumors predicts outcome in head and neck cancer
A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue ...
Cancer
6 hours ago |
not rated yet |
0
Molecular marker from pancreatic 'juices' helps identify pancreatic cancer
Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis—two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic ...
Cancer
6 hours ago |
not rated yet |
0
New smartphone application improves colonoscopy preparation
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer
May 19, 2013 |
not rated yet |
0
New study identifies risk factors for depression among COPD patients
Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall ...
Inflammatory bowel disease raises risk of melanoma
Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...
Pharmaceutical advances offer new options for health outcomes
Research presented at Digestive Disease Week (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C.
Stress test may help predict increased mortality risk in sleep apnea patients
Many studies have shown that men and women who suffer from obstructive sleep apnea (OSA) - a disorder that causes breathing to halt intermittently during sleep – have a higher mortality rate than those who do not have the ...
Study finds improved CPR quality saves lives
(Medical Xpress)—Life-saving CPR has been a foundation of emergency medicine for more than a half century. But researchers at the University of Arizona College of Medicine-Phoenix are continuing to refine the procedure, ...
Source of infection affects hospital mortality in septic shock patients in the ICU
In ICU patients who have septic shock, the anatomic source of infection has a strong effect on the chances of survival, according to a new study from researchers in Canada.
